| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Targeting the Notch1 and mTOR pathways in a mouse T-ALL model. | Blood | 2009 | 2.29 |
| 2 | Met activation in non-small cell lung cancer is associated with de novo resistance to EGFR inhibitors and the development of brain metastasis. | Am J Pathol | 2010 | 1.30 |
| 3 | Downregulation of Notch pathway by a gamma-secretase inhibitor attenuates AKT/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model. | Cancer Res | 2010 | 1.19 |
| 4 | Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration. | Hum Mol Genet | 2009 | 1.18 |
| 5 | A quantitative volumetric micro-computed tomography method to analyze lung tumors in genetically engineered mouse models. | Neoplasia | 2009 | 0.94 |
| 6 | Apolipoprotein E genotype and neurological disease onset in Niemann-Pick disease, type C1. | Am J Med Genet A | 2012 | 0.79 |